Skip to main content
European Molecular Biology Laboratory

European Molecular Biology Laboratory

Search complete. 60 mentions across 8 episodes found for "European Molecular Biology Laboratory".

Nov 6, 2026

Angus LamondHOST
0:00
Welcome to the EMBL Alumni Chats podcast sponsored by EMBLEm Technology Transfer.
Thomas VaccariNARRATOR
0:06
In this episode, former EMBL group leader Gareth Griffiths speaks about his decades-long career in cell biology, his experiences at the forefront of electron microscopy advancements at EMBL, and his concerns about the decline in usage of this technique.
Thomas VaccariNARRATOR
0:24
This interview is conducted by former EMBL group leader Angus Lamond.
Thomas VaccariNARRATOR
0:28
It was recorded in April 2024.
Thomas VaccariNARRATOR
0:32
So what was
Angus LamondHOST
0:33
the EMBL like back in the 1970s? What was the cell biology department like?
Gareth GriffithsGUEST
0:39
Well, the whole place was wild.
Gareth GriffithsGUEST
0:41
There were about 50 people then, altogether then.
Peter SchmidtHOST
2:47
This special interest group, SICK for short, has been quite busy since the launch two years ago, which brings me to this bite-sized session.
Peter SchmidtHOST
2:56
Because together with the European Molecular Biology Laboratory and its European Bioinformatics Institute, the short version of which is EMBL-EBI, they organise a series of online courses this autumn.
Peter SchmidtHOST
3:09
all around green computing.
Peter SchmidtHOST
3:12
In four sessions, they'll touch on the various aspects of green computing and I will come back to all of that at the end of this episode.
Ben LinfordHOST
9:33
But those variations turn out to actually follow rules.
Ben LinfordHOST
9:37
The teams who studied this came from EMBL, which is the German Cancer Research Center, and the Wellcome Sanger Institute.
Ben LinfordHOST
9:43
They found the same spatial arrangement of cell states in tumors from 12 different patients.
Ben LinfordHOST
9:50
They then worked with a deep learning framework called SCDORI, which traces the regulators steering those switches across more than a million patient-derived cells.
Stephen HansenHOST
1:05
Prior to Gilda, he was CFO and Chief of Portfolio Strategy for the biotech company PureTech Health, and before that, also spent 12 years as Partner and Portfolio Manager at LSP, investing in public biotechs.
Stephen HansenHOST
1:21
Joep holds a PhD in molecular biology from the European Molecular Biology Laboratory and a master's in biochemistry from the University of Nijmegen.
Stephen HansenHOST
1:31
Joep, I've got two things for you.
Stephen HansenHOST
1:33
First, welcome to the Biocentury Show.
speaker_0NARRATOR
0:36
It was recorded in April 2024.
Frank GannonGUEST
0:39
First of all, I'm Frank Gannon and I was the director of EMBO, but also significantly I was at various stages, I think the scientific director of EMBL was the first thing and then it became senior scientists and various roles in EMBL that I'll come to later on.
Frank GannonGUEST
0:57
But how I got here with circuitous.
Frank GannonGUEST
1:01
I did my PhD in England, postdoc in America, postdoc and position in Strasbourg in France.
Frank GannonGUEST
3:10
They gave me the job and I was nervous because EMBO was a huge, well-organised, big organisation, huge reputation.
Frank GannonGUEST
3:22
I'd been an EMBO member and proud to be one.
Frank GannonGUEST
3:26
And EMBL was even a larger laboratory at a scale and quality that was unsurpassed.
Frank GannonGUEST
3:32
So coming in as in a key position in that world had me slightly concerned.
Jim Al-KhaliliHOST
21:03
Well, this obviously helped further your reputation.
Jim Al-KhaliliHOST
21:06
And in 2019, you accepted the role of Director General of the prestigious European Molecular Biology Laboratory, known as EMBL or EMBL.
Jim Al-KhaliliHOST
21:17
I know you were enjoying your lab work.
Jim Al-KhaliliHOST
21:18
So did you have any qualms about taking on this new and quite different role?
Edith HeardGUEST
21:24
I kind of realised that maybe it would be useful for someone like me, a scientist who had had a very active and successful career, to take on a bigger role in an organisation that was designed to try and help support European science as a whole.
Edith HeardGUEST
21:44
And so when I started at EMBL, I was asked to come up with a whole new program accelerating into research areas that no other institute alone could do.
Edith HeardGUEST
21:57
EMBL being funded by 27 at the time, now 30 member states, it needed to do something that was ahead of the game.
Edith HeardGUEST
22:05
So we came up with a program that was called Molecules to Ecosystems.
Karsten Michael WarwasGUEST
8:09
Yeah, where to start? So I think Heidelberg is, I would say, quite a unique place, especially for oncology, because we have all those research institutions.
Karsten Michael WarwasGUEST
8:22
We have the EMBL, which is the European Molecular, what's it called? Uh, I don't know really the abbreviation, but, uh, you know, like, for for molecular science, we have that, um, institute and of course, the German cancer research center, which is, uh, quite big and focus on cancer.
Karsten Michael WarwasGUEST
8:42
Um, then here at the national center for tumor disease density, um, we have to focus on on, uh, research and translational research.
Karsten Michael WarwasGUEST
8:50
So.
Thomas VaccariHOST
0:00
Welcome to the EMBL Alumni Chats podcast, sponsored by EMBL Technology Transfer.
Thomas VaccariHOST
0:07
In this episode, EMBL's very first communications officer, David States, discusses his project of documenting EMBL's 20-year history in 1994.
Thomas VaccariHOST
0:18
David also speaks on the significance of clear and persuasive communication in science, emphasizing the need for scientists to convey their ideas to non-experts.
Thomas VaccariHOST
0:30
This interview was conducted by former EMBL group leader Angus Lamond, and it was recorded in March 2024.
David StatesGUEST
0:37
My name's David States.
David StatesGUEST
0:38
I was at, uh, EMBL from, I believe, '93 to '96, '97, sometime around there.
David StatesGUEST
0:47
Um, I live in, uh, Santa Cruz, California, and have done so for the last 20 years since I left Heidelberg.
Angus LamondHOST
0:55
David, it's great to see you again.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.